Doktorand:
Marjanović, Irena M.
Fakultet:
Biološki fakultet
Napomena:
Rok za dostavljanje primedbi na doktorsku disertaciju je istekao.
Datum postavljanja na uvid javnosti:
12-12-2017
Datum odbrane:
12-03-2018
Objavljeni radovi:
[1]
1. Marjanovic I, Karan-Djurasevic T, Ugrin M, Virijevic M, Vidovic A, Tomin D, Suvajdzic Vukovic N, Pavlovic S, Tosic N. “Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients.“ Clin Lymphoma Myeloma Leuk. 2017 May;17(5):312-319. M22
[2]
2. Marjanovic I, Kostic J, Stanic B, Pejanovic N, Lucic B, Karan-Djurasevic T, Janic D, Dokmanovic L, Jankovic S, Vukovic NS, Tomin D, Perisic O, Rakocevic G5, Popovic M, Pavlovic S, Tosic N. „Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease.“ Tumor Biol. 2016 Oct;37(10):13391-13401. M22
[3]
3. Virijevic M, Karan-Djurasevic T, Marjanovic I, Tosic N, Mitrovic M, Djunic I, Colovic N, Vidovic A, Suvajdzic-Vukovic N, Tomin D, Pavlovic S. “Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype.” Radiol Oncol. 2016 Sep 8;50(4):385-393. M22
